Kilitch Drugs Shareholders Approve Material Subsidiary Stake Sale and Debt Conversion
Kilitch Drugs India Ltd 路 Extra Ordinary General Meeting 路 16 Nov 2026, 9:17 pm
Kilitch Drugs Shareholders Approve Material Subsidiary Stake Sale and Debt Conversion Kilitch Drugs (India) Ltd announced the approval of all four resolutions at its EGM held on 16th Nov'26 with requisite majorities. Shareholders unanimously passed a special resolution to sell the company's entire shareholding in its material subsidiary and an ordinary resolution to convert existing debt extended to the subsidiary into equity shares. Additionally, shareholders approved the appointments of Dr. Milind Kishor Madhani and Mr. Gautam Rajan as Non-Executive Independent Directors for five consecutive years each, with over 99.99% voting in favour. Total voter turnout stood at 73.02%.
Original exchange filing (PDF)
More announcements from Kilitch Drugs India Ltd
- Proceeding of EGM held today i.e. 16th November, 2026 路 16 Nov 2026
- Intimation under regulation 30 of the SEBI LODR regulations 2015, corrigendum to the Notice of Extra Ordinary General Meeting 路 13 Nov 2026
- We are submitting herewith the rectification of typo error in the outcome of Board meeting dated 22nd October, 2026 路 13 Nov 2026
- We are submitting herewith the outcome of the Board meeting 路 07 Nov 2026
- Kilitch Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 07 Nov 2026
- Submitting unaudited financials results for quarter ended 30.09.2026 路 07 Nov 2026
- KILITCH DRUGS (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 06 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 06 Nov 2026
